Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone ACetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02034552
What this trial is testing

Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Neoplasms
Bayer 68
Early research (Phase 1)Study completedNCT02230046
What this trial is testing

Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 102
Testing effectiveness (Phase 2)Ended earlyNCT03093272
What this trial is testing

Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT01756638
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 48
Not applicableStudy completedNCT01857908
What this trial is testing

A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone

Who this might be right for
Prostate Cancer (Adenocarcinoma)
University Health Network, Toronto 20
Not applicableApproved For MarketingNCT05401214
What this trial is testing

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Early research (Phase 1)Study completedNCT00600535
What this trial is testing

A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer

Who this might be right for
Prostate Neoplasms
Cougar Biotechnology, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT04556617
What this trial is testing

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Opna Bio LLC 19
Early research (Phase 1)Study completedNCT01634061
What this trial is testing

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)WithdrawnNCT06329830
What this trial is testing

177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Baptist Health South Florida
Post-approval studies (Phase 4)Study completedNCT02116582
What this trial is testing

Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Europe B.V. 215
Testing effectiveness (Phase 2)Study completedNCT01751451
What this trial is testing

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 124
Large-scale testing (Phase 3)Study completedNCT01517802
What this trial is testing

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Breast Cancer
Janssen Research & Development, LLC 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02807805
What this trial is testing

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 37
Early research (Phase 1)Study completedNCT02924766
What this trial is testing

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 34
Not applicableStudy completedNCT02663193
What this trial is testing

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Who this might be right for
Prostate Cancer
Janssen Scientific Affairs, LLC 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262154
What this trial is testing

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04194554
What this trial is testing

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 102
Next Page